Milestone Scientific Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | $10.3M | $5.4M | $8.4M | $9.6M |
| Cost of Revenue | $2.6M | $2.2M | $3.0M | $3.9M | $4.0M | $1.8M | $2.7M | $5.2M |
| Gross Profit | $6.4M | $6.4M | $6.8M | $4.9M | $6.3M | $3.6M | $5.7M | $4.4M |
| Gross Margin | 71.4% | 74.6% | 69.1% | 55.7% | 61.3% | 66.6% | 68.3% | 46.1% |
| Operating Expenses | ||||||||
| Research & Development | $449.5K | $858.8K | $701.4K | $1.2M | $878.2K | $307.9K | $189.9K | $245.6K |
| SG&A Expense | $11.6M | $12.3M | $13.1M | $12.5M | $12.7M | $10.7M | $9.5M | $10.6M |
| Operating Income | $-5.7M | $-6.8M | $-7.1M | $-8.8M | $-7.4M | $-7.5M | $-4.0M | $-8.0M |
| Operating Margin | -63.5% | -78.3% | -72.3% | -100.2% | -71.6% | -137.1% | -47.8% | -83.1% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-5.7M | $-4.7M | $-7.0M | $-8.8M | $-7.1M | $-7.5M | $-7.6M | $-8.0M |
| Income Tax Expense | — | — | $0 | $0 | $333 | $15.5K | $18.1K | $24.0K |
| Net Income | $-5.7M | $-4.7M | $-6.9M | $-8.7M | $-6.8M | $-7.3M | $-7.5M | $-7.4M |
| Net Margin | -63.8% | -54.6% | -70.5% | -98.9% | -66.2% | -134.9% | -89.8% | -77.2% |
| EPS (Basic) | $-0.07 | $-0.06 | $-0.10 | $-0.12 | $-0.10 | $-0.12 | $-0.16 | $-0.21 |
| EPS (Diluted) | $-0.07 | $-0.06 | — | — | $-0.10 | $-0.12 | $-0.16 | $-0.21 |
| Shares Outstanding (Basic) | 82.1M | 79.8M | 72.8M | 70.6M | 68.8M | 63.1M | 45.7M | 35.3M |
| Shares Outstanding (Diluted) | 82.1M | 79.8M | 72.8M | 70.6M | 68.8M | 63.1M | 45.7M | 35.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |